{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:32:15Z","timestamp":1776418335467,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00216-011-5581-3","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T19:12:33Z","timestamp":1323976353000},"page":"1611-1623","source":"Crossref","is-referenced-by-count":52,"title":["Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry"],"prefix":"10.1007","volume":"402","author":[{"given":"Bjorn J. A.","family":"Berendsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin S.","family":"Wegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martien L.","family":"Essers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida A. M.","family":"Stolker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,16]]},"reference":[{"key":"5581_CR1","unstructured":"EC (2002) Commission Decision 2002\/657\/EC of 12 August 2002 implementing Council Directive 96\/23\/EC concerning the performance of analytical methods and the interpretation of results. Off J Europ Commun L221:8\u201336"},{"key":"5581_CR2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","volume":"353","author":"The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A\/H5","year":"2005","unstructured":"The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A\/H5 (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374\u20131385","journal-title":"N Engl J Med"},{"key":"5581_CR3","unstructured":"WHO (2011) Avian influenza, fact sheet. WHO, Geneva"},{"key":"5581_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","volume":"20","author":"JS Malik Peiris","year":"2007","unstructured":"Malik Peiris JS, De Jong MD, Guan Y (2007) Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20:243\u2013267","journal-title":"Clin Microbiol Rev"},{"key":"5581_CR5","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1177\/15648265070282S215","volume":"28","author":"E Mumford","year":"2007","unstructured":"Mumford E, Bishop J, Hendrickx S, Embarek P, Perdue M (2007) Avian influenza H5N1: risks at the human-animal interface. Food Nutr Bull 28:S357\u2013S363","journal-title":"Food Nutr Bull"},{"key":"5581_CR6","doi-asserted-by":"crossref","unstructured":"Von Itzstein M (2007) The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 6:967\u2013974","DOI":"10.1038\/nrd2400"},{"key":"5581_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2007.08.007","volume":"77","author":"G He","year":"2008","unstructured":"He G, Qiao J, Dong C, He C, Zhao L, Tian Y (2008) Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antivir Res 77:72\u201376","journal-title":"Antivir Res"},{"key":"5581_CR8","doi-asserted-by":"crossref","unstructured":"Souza TML, Mesquita M, Resende P, Machado V, Gregianini TS, Fernandes SB, Oliveira ICD, Rosa MdCD, Marinelli R, de Azeredo-Lima CH, Motta FC, Aguiar-Oliveira MdL, Siqueira MM (2011) Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir. Diag Microbiol Infect Dis 71:98\u201399","DOI":"10.1016\/j.diagmicrobio.2011.05.006"},{"key":"5581_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcv.2011.04.001","volume":"51","author":"H Zaraket","year":"2011","unstructured":"Zaraket H, Kondo H, Tabet C, Hanna-Wakim R, Suzuki Y, Dbaibo GS, Saito R, Suzuki H (2011) Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon. J Clin Virol 51:170\u2013174","journal-title":"J Clin Virol"},{"key":"5581_CR10","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.24262","volume":"53","author":"J-M Pawlotsky","year":"2011","unstructured":"Pawlotsky J-M (2011) Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 53:1742\u20131751","journal-title":"Hepatology"},{"key":"5581_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","volume":"203","author":"FG Hayden","year":"2011","unstructured":"Hayden FG, De Jong MD (2011) Emerging influenza antiviral resistance threats. J Infect Dis 203:6\u201310","journal-title":"J Infect Dis"},{"key":"5581_CR12","doi-asserted-by":"crossref","unstructured":"Thorlund K, Awad T, Boivin G, Thabane L (2011) Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis 11","DOI":"10.1186\/1471-2334-11-134"},{"key":"5581_CR13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2005.07.003","volume":"341","author":"NA Lyushina","year":"2005","unstructured":"Lyushina NA, Govorkova EA, Webster RG (2005) Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology 341:102\u2013106","journal-title":"Virology"},{"key":"5581_CR14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.295.8.jed60009","volume":"295","author":"DM Weinstock","year":"2006","unstructured":"Weinstock DM, Zuccotti G (2006) Adamantane resistance in influenza A. J Am Med Assoc 295:934\u2013936","journal-title":"J Am Med Assoc"},{"key":"5581_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1289\/ehp.0900930","volume":"118","author":"GC Ghosh","year":"2010","unstructured":"Ghosh GC, Nakada N, Yamashita N, Tanaka H (2010) Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ Health Persp 118:103\u2013107","journal-title":"Environ Health Persp"},{"key":"5581_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1289\/ehp.9574","volume":"115","author":"AC Singer","year":"2007","unstructured":"Singer AC, Nunn MA, Gould EA, Johnson AC (2007) Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 115:102\u2013106","journal-title":"Environ Health Perspect"},{"key":"5581_CR17","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.1371\/journal.pone.0000986","volume":"2","author":"J Fick","year":"2007","unstructured":"Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenstr\u00f6m J, Wallensten A, Olsen B (2007) Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS One 2:e986","journal-title":"PLoS One"},{"key":"5581_CR18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/4351009a","volume":"435","author":"D Cyranoski","year":"2005","unstructured":"Cyranoski D (2005) China's chicken farmers under fire for antiviral abuse. Nature 435:1009","journal-title":"Nature"},{"key":"5581_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","volume":"90","author":"I Delogu","year":"2011","unstructured":"Delogu I, Pastorino B, Baronti C, Nougair\u00e8de A, Bonnet E, de Lamballerie X (2011) In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antivir Res 90:99\u2013107","journal-title":"Antivir Res"},{"key":"5581_CR20","unstructured":"FDA (2006) FDA prohibits use of antiviral drugs in poultry to help keep drugs effective for humans. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2006\/ucm108620.htm . Accessed 18 Jun 2009"},{"key":"5581_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0378-4347(99)00306-0","volume":"732","author":"GD Allen","year":"1999","unstructured":"Allen GD, Brookes ST, Barrow A, Dunn JA, Grosse CM (1999) Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum. J Chromatogr B 732:383\u2013393","journal-title":"J Chromatogr B"},{"key":"5581_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jchromb.2007.02.006","volume":"852","author":"TM Baughman","year":"2007","unstructured":"Baughman TM, Wright WL, Hutton KA (2007) Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)\/tandem mass spectrometry. J Chromatogr B 852:505\u2013511","journal-title":"J Chromatogr B"},{"key":"5581_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpba.2004.12.006","volume":"38","author":"LT Yeh","year":"2005","unstructured":"Yeh LT, Nguyen M, Lourenco D, Lin CC (2005) A sensitive and specific method for the determination of total ribavirin in monkey liver by high-performance liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 38:34\u201340","journal-title":"J Pharm Biomed Anal"},{"key":"5581_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jpba.2006.09.001","volume":"43","author":"LT Yeh","year":"2007","unstructured":"Yeh LT, Nguyen M, Dadgostari S, Bu W, Lin CC (2007) LC-MS\/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells. J Pharm Biomed Anal 43:1057\u20131064","journal-title":"J Pharm Biomed Anal"},{"key":"5581_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2005.12.034","volume":"832","author":"Y Liu","year":"2006","unstructured":"Liu Y, Xu C, Yan R, Lim C, Yeh LT, Lin CC (2006) Sensitive and specific LC-MS\/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma. J Chromatography B 832:17\u201323","journal-title":"J Chromatography B"},{"key":"5581_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007691-200004000-00013","volume":"22","author":"JO Svensson","year":"2000","unstructured":"Svensson JO, Bruchfeld A, Schvarcz R, St\u00e5hle L (2000) Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography. Ther Drug Monit 22:215\u2013218","journal-title":"Ther Drug Monit"},{"key":"5581_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2007.09.018","volume":"859","author":"N Lindeg\u00e5rdh","year":"2007","unstructured":"Lindeg\u00e5rdh N, Hanpithakpong W, Wattanagoon Y, Singhasivanon P, White NJ, Day NPJ (2007) Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. J Chromatogr B Anal Technol Biomed Life Sci 859:74\u201383","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"5581_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0378-4347(00)00300-5","volume":"745","author":"B Wiltshire","year":"2000","unstructured":"Wiltshire B, Citron A, Clarke T, Serpe C, Gray D, Herron W (2000) Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64\u20130802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B 745:373\u2013388","journal-title":"J Chromatogr B"},{"key":"5581_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1292\/jvms.69.293","volume":"69","author":"T Yamanaka","year":"2007","unstructured":"Yamanaka T, Yamada M, Tsujimura K, Kondo T, Nagata S, Hobo S, Kurosawa M, Matsumura T (2007) Clinical pharmacokinetics of oseltamivir and its active metabolite oseltamivir carboxylate after oral administration in horses. J Vet Med Sci 69:293\u2013296","journal-title":"J Vet Med Sci"},{"key":"5581_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jchromb.2008.10.037","volume":"876","author":"K Heinig","year":"2008","unstructured":"Heinig K, Bucheli F (2008) Sensitive determination of oseltamivir and oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and brain by liquid chromatography-tandem mass spectrometry. J Chromatogr B 876:129\u2013136","journal-title":"J Chromatogr B"},{"key":"5581_CR31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jchromb.2008.01.048","volume":"864","author":"G Bahrami","year":"2008","unstructured":"Bahrami G, Mohammadi B, Kiani A (2008) Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performance liquid chromatography with UV detection. J Chromatogr B 864:38\u201342","journal-title":"J Chromatogr B"},{"key":"5581_CR32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jpba.2006.10.044","volume":"43","author":"W Ping","year":"2007","unstructured":"Ping W, Yi-Zeng L, Ben-Mei C, Neng Z, Lun-Zhao Y, Yan Y, Zhi-Biao Y (2007) Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study. J Pharm Biomed Anal 43:1519\u20131525","journal-title":"J Pharm Biomed Anal"},{"key":"5581_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2008.01.053","volume":"864","author":"M Xu","year":"2008","unstructured":"Xu M, Ju W, Xia X, Tan H, Chen M, Zhang J, Xiong N, Jiang M, Chen L, Gong L (2008) Determination of rimantadine in rat plasma by liquid chromatography\/electrospray mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B 864:123\u2013128","journal-title":"J Chromatogr B"},{"key":"5581_CR34","first-page":"86","volume":"59","author":"S Feng","year":"2009","unstructured":"Feng S, Tian Y, Zhang Z, Zhang J, Huang M, Chen Y (2009) Rapid simultaneous determination of paracetamol, amantadine hydrochloride, caffeine and chlorpheniramine maleate in human plasma by liquid chromatography\/ tandem mass spectrometry. Arzneim Forsch 59:86\u201395","journal-title":"Arzneim Forsch"},{"key":"5581_CR35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bmc.492","volume":"19","author":"Y Higashi","year":"2005","unstructured":"Higashi Y, Uemori I, Fujii Y (2005) Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies. Biomed Chromatogr 19:655\u2013662","journal-title":"Biomed Chromatogr"},{"key":"5581_CR36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jpba.2007.04.021","volume":"44","author":"C Shuangjin","year":"2007","unstructured":"Shuangjin C, Fang F, Han L, Ming M (2007) New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma. J Pharm Biomed Anal 44:1100\u20131105","journal-title":"J Pharm Biomed Anal"},{"key":"5581_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpba.2006.06.039","volume":"43","author":"X Liu","year":"2007","unstructured":"Liu X, Huang YW, Li J, Li XB, Bi KS, Chen XH (2007) Determination of arbidol in human plasma by LC-ESI-MS. J Pharm Biomed Anal 43:371\u2013375","journal-title":"J Pharm Biomed Anal"},{"key":"5581_CR38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jms.1394","volume":"43","author":"Y Wang","year":"2008","unstructured":"Wang Y, Chen X, Li Q, Zhong D (2008) Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry. J Mass Spectrom 43:1099\u20131109","journal-title":"J Mass Spectrom"},{"key":"5581_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.aca.2010.11.015","volume":"700","author":"D Chan","year":"2011","unstructured":"Chan D, Tarbin J, Sharman M, Carson M, Smith M, Smith S (2011) Screening method for the analysis of antiviral drugs in poultry tissues using zwitterionic hydrophilic interaction liquid chromatography\/tandem mass spectrometry. Anal Chim Acta 700:194\u2013200","journal-title":"Anal Chim Acta"},{"key":"5581_CR40","first-page":"1344","volume":"63","author":"W Horwitz","year":"1980","unstructured":"Horwitz W, Kamps LR, Boyer KW (1980) Quality assurance in the analysis of foods and trace constituents. J Assoc Off Anal Chem 63:1344\u20131354","journal-title":"J Assoc Off Anal Chem"},{"key":"5581_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1351\/pac200678010145","volume":"78","author":"M Thompson","year":"2006","unstructured":"Thompson M, Ellison SL, Wood R (2006) The international harmonized protocol for the proficiency testing of analytical chemistry laboratories. Pure Appl Chem 78:145\u2013196","journal-title":"Pure Appl Chem"},{"key":"5581_CR42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0003-2670(02)01379-X","volume":"483","author":"J-P Antignac","year":"2003","unstructured":"Antignac J-P, Le Bizec BL, Monteau F, Andre F (2003) Validation of analytical methods based on mass spectrometric detection according to the \u201c2002\/657\/EC\u201d European decision: guideline and application. Anal Chim Acta 483:325\u2013334","journal-title":"Anal Chim Acta"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00216-011-5581-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:22:01Z","timestamp":1561076521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-011-5581-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,16]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["5581"],"URL":"https:\/\/doi.org\/10.1007\/s00216-011-5581-3","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,16]]}}}